{"symbol": "EXAS", "companyName": "Exact Sciences Corp.", "exchange": "NASDAQ", "industry": "Research and Development in Biotechnology ", "website": "www.exactsciences.com", "description": "A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.", "CEO": "Kevin Conroy", "securityName": "Exact Sciences Corp.", "issueType": "cs", "sector": "Professional, Scientific, and Technical Services", "primarySicCode": 8731, "employees": 2268, "tags": ["Health Technology", "Biotechnology"], "address": "5505 Endeavor Lane", "address2": null, "state": "Wisconsin", "city": "Madison", "zip": "53719", "country": "US", "phone": "16082845700"}